Together, the presented evidence suggested that WA can inhibit HCC cell proliferationand tumorigenesis through miR-22-repressed CCNA2, which was at least partially through FXR regulation (Figure 7). The gene discussed is CCNA2; the disease is hepatocellular carcinoma.